Who owns APIMEDS PHARMACEUTICALS US I COM?
- Ticker: APUS
- CUSIP Number: 03771d102
Tip: Access positions for across all investors
Analyze quarterly positions in Apimeds Pharmaceuticals Us I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Apimeds Pharmaceuticals Us I stock
Who bought or sold APIMEDS PHARMACEUTICALS US I COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hemenway Trust Company | 250k | $445k | 100% | Sep 2025 |
|
| Vanguard Group | 59k | $105k | 100% | Sep 2025 |
|
| Geode Capital Management | 31k | $55k | 100% | Sep 2025 |
|
| Renaissance Technologies | 28k | $50k | 100% | Sep 2025 |
|
| XTX Topco | 19k | $33k | 100% | Sep 2025 |
|
| Hrt Financial | 14k | $24k | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 8.00 | $14.000000 | 100% | Sep 2025 |
|
Who sold out of Apimeds Pharmaceuticals Us I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Yorkville Advisors Global | Jun 2025 | 250k | $440k |
| Citadel Advisors | Jun 2025 | 13k | $24k |
| Tower Research Capital | Jun 2025 | 3.2k | $5.5k |